Drug major Cipla Tuesday said its South African subsidiary has completed the acquisition of pharma firm Mirren (Pty) Ltd.
Cipla Medpro South Africa (Pty) Ltd has completed the acquisition of 100 per cent stake in South African firm Mirren on October 22, 2018, Cipla said in a filing to BSE.
In July, the company informed that Cipla Medpro had signed an agreement to fully acquire Mirren for a cash consideration of South African Rand 450 million to be paid on closing of transaction.
Cipla Medpro is a wholly-owned subsidiary of Mumbai-based Cipla Ltd.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.